Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Novel approach to an early assessment of a patient's potential for neurological remission after acute spinal cord injury: Analysis of hemoglobin concentration dynamics.

Biglari B, Heller RA, Hörner M, Sperl A, Bock T, Reible B, Haubruck P, Grützner PA, Moghaddam A.

J Spinal Cord Med. 2019 Jun 18:1-12. doi: 10.1080/10790268.2019.1632060. [Epub ahead of print]

PMID:
31211658
2.

Relation of selenium status to neuro-regeneration after traumatic spinal cord injury.

Heller RA, Seelig J, Bock T, Haubruck P, Grützner PA, Schomburg L, Moghaddam A, Biglari B.

J Trace Elem Med Biol. 2019 Jan;51:141-149. doi: 10.1016/j.jtemb.2018.10.006. Epub 2018 Oct 12.

PMID:
30466924
3.

Making the weekend work: a local quality improvement project to establish and improve the quality of weekend handover.

Heller RA, Hu L.

BMJ Open Qual. 2018 Jul 25;7(3):e000215. doi: 10.1136/bmjoq-2017-000215. eCollection 2018.

4.

CCL-2 as a possible early marker for remission after traumatic spinal cord injury.

Heller RA, Raven TF, Swing T, Kunzmann K, Daniel V, Haubruck P, Akbar M, Grützner PA, Schmidmaier G, Biglari B, Moghaddam A.

Spinal Cord. 2017 Nov;55(11):1002-1009. doi: 10.1038/sc.2017.69. Epub 2017 Jun 20.

PMID:
28631748
5.

Gene microarray analysis of multiple sclerosis lesions.

Lock CB, Heller RA.

Trends Mol Med. 2003 Dec;9(12):535-41. Review. No abstract available.

PMID:
14659468
7.

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans.

Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, Lollini L, Morris D, Kim Y, DeLustro B, Sheppard D, Pardo A, Selman M, Heller RA.

Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6292-7.

8.

Use of oligonucleotide microarrays to analyze gene expression patterns in pulmonary fibrosis reveals distinct patterns of gene expression in mice and humans.

Kaminski N, Zuo F, Cojocaro G, Yakhini Z, Ben-Dor A, Morris D, Sheppard D, Pardo A, Selman M, Heller RA.

Chest. 2002 Mar;121(3 Suppl):31S-32S. No abstract available.

PMID:
11893671
9.

Use of oligonucleotide arrays to analyze drug toxicity.

Kaminski N, Allard J, Heller RA.

Ann N Y Acad Sci. 2000;919:1-8.

PMID:
11083091
10.

Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis.

Kaminski N, Allard JD, Pittet JF, Zuo F, Griffiths MJ, Morris D, Huang X, Sheppard D, Heller RA.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1778-83.

11.

Quantitative B-hCG levels less than 1000 mIU/mL in patients with ectopic pregnancy: pelvic ultrasound still useful.

Counselman FL, Shaar GS, Heller RA, King DK.

J Emerg Med. 1998 Sep-Oct;16(5):699-703.

PMID:
9752940
12.

Microarrays: biotechnology's discovery platform for functional genomics.

Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW.

Trends Biotechnol. 1998 Jul;16(7):301-6. Review.

PMID:
9675914
13.

Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.

Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, Woolley DE, Davis RW.

Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2150-5.

14.

Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases.

Borden P, Heller RA.

Crit Rev Eukaryot Gene Expr. 1997;7(1-2):159-78. Review.

PMID:
9034720
15.

Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes.

Borden P, Solymar D, Sucharczuk A, Lindman B, Cannon P, Heller RA.

J Biol Chem. 1996 Sep 20;271(38):23577-81. Erratum in: J Biol Chem 1996 Dec 27;271(52):33706.

16.

The human stromelysin promoter contains a previously unreported 1.0-kb sequence.

Borden P, Song K, Heller RA.

Gene. 1994 Dec 30;151(1-2):315-20.

PMID:
7828897
17.
18.

Tumor necrosis factor receptor-mediated signaling pathways.

Heller RA, Krönke M.

J Cell Biol. 1994 Jul;126(1):5-9. Review. No abstract available.

20.

Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis.

Hoeck WG, Ramesha CS, Chang DJ, Fan N, Heller RA.

Proc Natl Acad Sci U S A. 1993 May 15;90(10):4475-9.

21.
22.

The p70 tumor necrosis factor receptor mediates cytotoxicity.

Heller RA, Song K, Fan N, Chang DJ.

Cell. 1992 Jul 10;70(1):47-56.

PMID:
1320461
23.

CCAAT/enhancer binding protein expression is rapidly extinguished in TA1 adipocyte cells treated with tumor necrosis factor.

Williams PM, Chang DJ, Danesch U, Ringold GM, Heller RA.

Mol Endocrinol. 1992 Jul;6(7):1135-41.

PMID:
1508226
24.
25.

Tumor necrosis factor receptor genes, TNFR1 and TNFR2, on human chromosomes 12 and 1.

Milatovich A, Song K, Heller RA, Francke U.

Somat Cell Mol Genet. 1991 Sep;17(5):519-23.

PMID:
1662415
26.

Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.

Heller RA, Song K, Onasch MA, Fischer WH, Chang D, Ringold GM.

Proc Natl Acad Sci U S A. 1990 Aug;87(16):6151-5.

27.

Amplified expression of tumor necrosis factor receptor in cells transfected with Epstein-Barr virus shuttle vector cDNA libraries.

Heller RA, Song K, Villaret D, Margolskee R, Dunne J, Hayakawa H, Ringold GM.

J Biol Chem. 1990 Apr 5;265(10):5708-17.

28.

Multiple forms and cellular localization of Drosophila DNA topoisomerase II.

Heller RA, Shelton ER, Dietrich V, Elgin SC, Brutlag DL.

J Biol Chem. 1986 Jun 15;261(17):8063-9.

29.
30.

Development of monoclonal antibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Heller RA, Hoy P, Jones PP.

Biochem Biophys Res Commun. 1982 May 31;106(2):412-21. No abstract available.

PMID:
7104002
31.

Immunotitration of 3-hydroxy-3-methylglutaryl-CoA reductase.

Scallen TJ, Hardgrave JE, Heller RA.

Methods Enzymol. 1981;74 Pt C:320-42. No abstract available.

PMID:
6798367
32.

Immunotitration of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in various physiological states.

Hardgrave JE, Heller RA, Herrera MG, Scallen TJ.

Proc Natl Acad Sci U S A. 1979 Aug;76(8):3834-8.

33.
34.
35.

Activation of purified 3-hydroxy-3-methylglutaryl-CoA reductase by phospholipids.

Berde CB, Heller RA, Simoni RD.

Biochim Biophys Acta. 1977 Jul 20;488(1):112-20.

PMID:
889851
36.
37.

Prevention of cold inactivation of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase by NADPH.

Heller RA, Gould RG.

Biochim Biophys Acta. 1975 May 22;388(2):254-9.

PMID:
237546
38.

Reversible cold inactivation of microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase from rat liver.

Heller RA, Gould RG.

J Biol Chem. 1974 Aug 25;249(16):5254-60. No abstract available.

39.

Endontics in a capuchin monkey: reduction in the length of the canine crown.

Ross DL, Heller RA.

Vet Med Small Anim Clin. 1973 Mar;68(3):255-60. No abstract available.

PMID:
4211269
40.

Solubilization and partial purification of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Heller RA, Gould RG.

Biochem Biophys Res Commun. 1973 Feb 5;50(3):859-65. No abstract available.

PMID:
4689083
41.

Partial glyceridase activity of a protein-kinase activatable triglyceride lipase from rat adipose tissue.

Heller RA, Steinberg D.

Biochim Biophys Acta. 1972 May 23;270(1):65-73. No abstract available.

PMID:
4338741
42.

Surgical correction of prolapse of the male urethra.

Hobson HP, Heller RA.

Vet Med Small Anim Clin. 1971 Dec;66(12):1177-9. No abstract available.

PMID:
5209512
43.

Use of a removable maxillary appliance to correct a palatal defect in a dog.

Hobson HP, Heller RA, Wilson JB.

Vet Med Small Anim Clin. 1971 Nov;66(11):1085-7. No abstract available.

PMID:
5209414
44.

Three cases of phycomycosis in dogs.

Heller RA, Hobson HP, Gowing GM, Storts RW, Read WK, Bridges CH.

Vet Med Small Anim Clin. 1971 May;66(5):472-6. No abstract available.

PMID:
4930357

Supplemental Content

Loading ...
Support Center